Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Trial of Intratumoral DTI-015 for Recurrent Malignant Gliomas
NCT00038441Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 1995
- Primary completion
- Feb 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carmustine in malignant glioma, sponsored by University of Texas MD Anderson Cancer Center. Started Sep 1995; status: completed.
02
Drugs
carmustine
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00038441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038441.